Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248.
Treon SP, Hunter ZR, Matous J, Joyce RM, Mannion B, Advani R, Cook D, Songer J, Hill J, Kaden BR, Sharon D, Steiss R, Leleu X, Branagan AR, Badros A.
Treon SP, et al.
Clin Cancer Res. 2007 Jun 1;13(11):3320-5. doi: 10.1158/1078-0432.CCR-06-2511.
Clin Cancer Res. 2007.
PMID: 17545538
Clinical Trial.